Interestingly, recent research indicated that S100A9 could be one marker for circulatory MDSCs (38), and other studies showed that MDSCs from tumor-bearing mice or peripheral blood in cancer patients express and secrete S100A9 in an autocrine manner (37). This evidence concerns the gene S100A9 and cancer.